Methylprednisolone Unknown Status Phase 4 Trials for Behcet's Syndrome Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01306955The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease